Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)
Clinical trial NCT00384111 · TERMINATED
Trial details
- NCT number
- NCT00384111
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2008-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.